Six institutions have joined in the creation of the Massachusetts Alzheimer's Disease Research Center (ADRC): four Harvard- affiliated hospitals (Massachusetts General, Brigham and Women's, Beth Israel, and McLean Hospitals); the University of Massachusetts Medical Center; and Massachusetts Institute of Technology. This regional consortium unites a large group of researchers and clinicians with established and potential interests in Alzheimer's disease (AD); it capitalizes on formalized interactions and focuses efforts on improving the diagnosis, understanding the basic mechanisms, and developing treatments for AD. By creating a research capacity and collective intelligence that exceeds the sum of its parts, the Center stimulates investigations b the exchange of ideas, techniques, and experience. A Clinical Core comprising units at MGH, BIH, and UMMC has been established to enroll, diagnose, and follow patients with dementia, provide a pool of patients for clinical investigation, and to collect systematic clinical data regarding the features of AD. A Data Management Core has been established to store information on all patients in the clinical units and all postmortem examinations; personnel in this Core also assist in protocol design and statistical analyses. A Neuropathology Core establishes diagnoses on all brains obtained, and operates a brain bank, storing tissue of AD patients suitable for chemical, histologic, histochemical, and immunocytochemical studies. Research projects examine major issues in AD: new diagnostic methods; reliable information on clinical course; genetic and biochemical aspects of its etiology; the identity and quantity of neural elements affected; and the biologic basis of clinical manifestations. Through the Harvard Geriatric Educational Center, professional training and continuing medical education programs have been expanded. Quarterly workshops on topics of fundamental neurobiological importance are planned with visiting scientists to exchange ideas with ADRC members.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-04
Application #
3104746
Study Section
Aging Review Committee (AGE)
Project Start
1984-09-28
Project End
1989-08-31
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Makaretz, Sara J; Quimby, Megan; Collins, Jessica et al. (2018) Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry 89:1024-1031
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Wimalaratne, Sarala M; Juty, Nick; Kunze, John et al. (2018) Uniform resolution of compact identifiers for biomedical data. Sci Data 5:180029
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci U S A 115:409-414
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307

Showing the most recent 10 out of 966 publications